188 related articles for article (PubMed ID: 35186791)
1. Isolation of SARS-CoV-2 in Viral Cell Culture in Immunocompromised Patients With Persistently Positive RT-PCR Results.
Sung A; Bailey AL; Stewart HB; McDonald D; Wallace MA; Peacock K; Miller C; Reske KA; O'Neil CA; Fraser VJ; Diamond MS; Burnham CD; Babcock HM; Kwon JH
Front Cell Infect Microbiol; 2022; 12():804175. PubMed ID: 35186791
[TBL] [Abstract][Full Text] [Related]
2. Prolonged viral shedding of SARS-CoV-2 in an immunocompromised patient.
Nakajima Y; Ogai A; Furukawa K; Arai R; Anan R; Nakano Y; Kurihara Y; Shimizu H; Misaki T; Okabe N
J Infect Chemother; 2021 Feb; 27(2):387-389. PubMed ID: 33328135
[TBL] [Abstract][Full Text] [Related]
3. Test-based de-isolation in COVID-19 immunocompromised patients: Cycle threshold value versus SARS-CoV-2 viral culture.
Alshukairi AN; Tolah AM; Dada A; Al-Tawfiq JA; Almagharbi RS; Saeedi MF; Al-Hamzi MA; El-Kafrawy SA; Bahaudden HA; El-Saed A; Al-Mozaini MA; Khalid I; Hefni LK; Hassan AM; Alandijany TA; Bajrai LH; Bayumi DT; Albishi GE; Althawadi SI; Zabani NA; Perlman S; Azhar EI
Int J Infect Dis; 2021 Jul; 108():112-115. PubMed ID: 34004329
[TBL] [Abstract][Full Text] [Related]
4. Shedding of Viable Virus in Asymptomatic SARS-CoV-2 Carriers.
Murata T; Sakurai A; Suzuki M; Komoto S; Ide T; Ishihara T; Doi Y
mSphere; 2021 May; 6(3):. PubMed ID: 34011679
[TBL] [Abstract][Full Text] [Related]
5. Clinical characteristics and potential factors for recurrence of positive SARS-CoV-2 RNA in convalescent patients: a retrospective cohort study.
Ao Z; Li Y; Wei J; Jiang J; Wang X; Zhang P; Liu Y; Yu H; Zhu L; Wang X; Hu Q; Duan J; Hu W; Zhang X; Wu G; Guo S
Clin Exp Med; 2021 Aug; 21(3):361-367. PubMed ID: 33543353
[TBL] [Abstract][Full Text] [Related]
6. Prolonged viral shedding of SARS-CoV-2 in two immunocompromised patients, a case report.
Niyonkuru M; Pedersen RM; Assing K; Andersen TE; Skov MN; Johansen IS; Madsen LW
BMC Infect Dis; 2021 Aug; 21(1):743. PubMed ID: 34344321
[TBL] [Abstract][Full Text] [Related]
7. Epidemiologic Characteristics Associated With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antigen-Based Test Results, Real-Time Reverse Transcription Polymerase Chain Reaction (rRT-PCR) Cycle Threshold Values, Subgenomic RNA, and Viral Culture Results From University Testing.
Ford L; Lee C; Pray IW; Cole D; Bigouette JP; Abedi GR; Bushman D; Delahoy MJ; Currie DW; Cherney B; Kirby MK; Fajardo GC; Caudill M; Langolf K; Kahrs J; Zochert T; Kelly P; Pitts C; Lim A; Aulik N; Tamin A; Harcourt JL; Queen K; Zhang J; Whitaker B; Browne H; Medrzycki M; Shewmaker PL; Bonenfant G; Zhou B; Folster JM; Bankamp B; Bowen MD; Thornburg NJ; Goffard K; Limbago B; Bateman A; Tate JE; Gieryn D; Kirking HL; Westergaard RP; Killerby ME;
Clin Infect Dis; 2021 Sep; 73(6):e1348-e1355. PubMed ID: 33846714
[TBL] [Abstract][Full Text] [Related]
8. [Evaluation of the Rapid Antigen Detection Kit with the Polymerase Chain Reaction for Detection of SARS-CoV-2 in Respiratory Samples].
Erman Daloğlu A; Er H; Sepin Özen N; Çekin Y
Mikrobiyol Bul; 2022 Apr; 56(2):263-273. PubMed ID: 35477229
[TBL] [Abstract][Full Text] [Related]
9. Viral culture and immunofluorescence for the detection of SARS-CoV-2 infectivity in RT-PCR positive respiratory samples.
Berengua C; López M; Esteban M; Marín P; Ramos P; Cuerpo MD; Gich I; Navarro F; Miró E; Rabella N
J Clin Virol; 2022 Jul; 152():105167. PubMed ID: 35523105
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Home Antigen Testing With RT-PCR and Viral Culture During the Course of SARS-CoV-2 Infection.
Chu VT; Schwartz NG; Donnelly MAP; Chuey MR; Soto R; Yousaf AR; Schmitt-Matzen EN; Sleweon S; Ruffin J; Thornburg N; Harcourt JL; Tamin A; Kim G; Folster JM; Hughes LJ; Tong S; Stringer G; Albanese BA; Totten SE; Hudziec MM; Matzinger SR; Dietrich EA; Sheldon SW; Stous S; McDonald EC; Austin B; Beatty ME; Staples JE; Killerby ME; Hsu CH; Tate JE; Kirking HL; Matanock A;
JAMA Intern Med; 2022 Jul; 182(7):701-709. PubMed ID: 35486394
[TBL] [Abstract][Full Text] [Related]
11. Prolonged SARS-CoV-2 infection following rituximab treatment: clinical course and response to therapeutic interventions correlated with quantitative viral cultures and cycle threshold values.
Thornton CS; Huntley K; Berenger BM; Bristow M; Evans DH; Fonseca K; Franko A; Gillrie MR; Lin YC; Povitz M; Shafey M; Conly JM; Tremblay A
Antimicrob Resist Infect Control; 2022 Feb; 11(1):28. PubMed ID: 35123573
[TBL] [Abstract][Full Text] [Related]
12. Epidemiologic, Immunologic, and Virus Characteristics in Patients With Paired Severe Acute Respiratory Syndrome Coronavirus 2 Serology and Reverse-Transcription Polymerase Chain Reaction Testing.
Shragai T; Smith-Jeffcoat SE; Koh M; Schechter MC; Rebolledo PA; Kasinathan V; Wang Y; Hoffman A; Miller H; Tejada-Strop A; Jain S; Tamin A; Harcourt JL; Thornburg NJ; Wong P; Medrzycki M; Folster JM; Semenova V; Steward-Clark E; Drobenuic J; Biedron C; Stewart RJ; da Silva J; Kirking HL; Tate JE;
J Infect Dis; 2022 Jan; 225(2):229-237. PubMed ID: 34216468
[TBL] [Abstract][Full Text] [Related]
13. Analysis of a persistent viral shedding patient infected with SARS-CoV-2 by RT-qPCR, FilmArray Respiratory Panel v2.1, and antigen detection.
Hirotsu Y; Maejima M; Shibusawa M; Amemiya K; Nagakubo Y; Hosaka K; Sueki H; Hayakawa M; Mochizuki H; Tsutsui T; Kakizaki Y; Miyashita Y; Omata M
J Infect Chemother; 2021 Feb; 27(2):406-409. PubMed ID: 33183963
[TBL] [Abstract][Full Text] [Related]
14. The Longest Persistence of Viable SARS-CoV-2 With Recurrence of Viremia and Relapsing Symptomatic COVID-19 in an Immunocompromised Patient-A Case Study.
Sepulcri C; Dentone C; Mikulska M; Bruzzone B; Lai A; Fenoglio D; Bozzano F; Bergna A; Parodi A; Altosole T; Delfino E; Bartalucci G; Orsi A; Di Biagio A; Zehender G; Ballerini F; Bonora S; Sette A; De Palma R; Silvestri G; De Maria A; Bassetti M
Open Forum Infect Dis; 2021 Nov; 8(11):ofab217. PubMed ID: 34796242
[TBL] [Abstract][Full Text] [Related]
15. [SARS-CoV-2 and Microbiological Diagnostic Dynamics in COVID-19 Pandemic].
Erensoy S
Mikrobiyol Bul; 2020 Jul; 54(3):497-509. PubMed ID: 32755524
[TBL] [Abstract][Full Text] [Related]
16. Predicting Infectious Severe Acute Respiratory Syndrome Coronavirus 2 From Diagnostic Samples.
Bullard J; Dust K; Funk D; Strong JE; Alexander D; Garnett L; Boodman C; Bello A; Hedley A; Schiffman Z; Doan K; Bastien N; Li Y; Van Caeseele PG; Poliquin G
Clin Infect Dis; 2020 Dec; 71(10):2663-2666. PubMed ID: 32442256
[TBL] [Abstract][Full Text] [Related]
17. Prolonged shedding of viable SARS-CoV-2 in immunocompromised patients with haematological malignancies: A prospective study.
Ichikawa T; Tamura T; Takahata M; Ishio T; Ibata M; Kasahara I; Minauchi K; Yamamoto S; Teshima T; Fukuhara T
Br J Haematol; 2024 Mar; 204(3):815-820. PubMed ID: 37795527
[TBL] [Abstract][Full Text] [Related]
18. Detectable Duration of Viable SARS-CoV-2, Total and Subgenomic SARS-CoV-2 RNA in Noncritically Ill COVID-19 Patients: a Prospective Cohort Study.
Phuphuakrat A; Pasomsub E; Srichatrapimuk S; Kirdlarp S; Suksatu A; Srisaowakarn C; Manopwisedjaroen S; Ludowyke N; Purwono PB; Priengprom T; Wongsa A; Thakkinstian A; Hongeng S; Malathum K; Thitithanyanont A; Tassaneetrithep B
Microbiol Spectr; 2022 Jun; 10(3):e0050322. PubMed ID: 35604133
[TBL] [Abstract][Full Text] [Related]
19. Diabetes mellitus is a risk factor for prolonged SARS-CoV-2 viral shedding in lower respiratory tract samples of critically ill patients.
Buetti N; Trimboli P; Mazzuchelli T; Lo Priore E; Balmelli C; Trkola A; Conti M; Martinetti G; Elzi L; Ceschi A; Consonni V; Ogna A; Forni-Ogna V; Bernasconi E
Endocrine; 2020 Dec; 70(3):454-460. PubMed ID: 32870469
[TBL] [Abstract][Full Text] [Related]
20. Comparison of a novel antigen detection test with reverse transcription polymerase chain reaction assay for laboratory diagnosis of SARS-CoV-2 infection.
Cirit OS; Mutlu E; Sancak B; Kocagöz T; Can Ö; Çicek C; Arzu Sayiner A; Appak Ö; Uyar NY; Külah C; Çiçek AÇ; Özgümüs OB; Ay Altintop Y; Saatçi E; Karsligil T; Zer Y; Özen NS; Çekin Y; Karahan ZC; Evren E; Karakoç AE; Orhan SG; Mutlu D; Bozdemir T; Çayci YT; Çinar C; Tasbakan M; Mert M; Çinar E; Kutsoylu OÖE; Kocagöz S; Ertürk A; Çelik I; Mete AÖ; Günalp Eneyli M; Akdemir I; Karakök T; Inan D; Atilla A; Taflan ŞO; Yörük KE
Infection; 2023 Feb; 51(1):91-96. PubMed ID: 35513690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
